Bayer CropScience Limited has made headlines with its announcement of an interim dividend of ₹90 per equity share for the financial year 2026-27, marking a significant 900% payout based on the face value of ₹10 per share. The company’s board of directors confirmed this decision on November 3, 2026, and set the record date for November 12, 2026, determining the eligibility of shareholders for this lucrative payout. Investors must hold the stock before this date to qualify for the dividend, which will be disbursed by November 30, 2026.
Financial Performance in Q2 FY27
In conjunction with the dividend announcement, Bayer CropScience reported a robust financial performance for the second quarter of FY27. The company recorded a net profit of ₹166.2 crore, a notable increase from ₹152.7 crore in the same quarter of the previous year. This 8.9% year-on-year growth reflects the company's resilience and strategic positioning in the competitive agricultural sector. Additionally, the net profit before tax (PBT) rose by 6% to ₹211.4 crore during the quarter, indicating effective cost management and operational efficiency.
The stock market reacted positively to the announcement, with Bayer CropScience shares closing 0.45% higher at ₹3316.50 on the [Bombay Stock Exchange](/topic/sensex) (BSE). Over the last five trading sessions, the stock has seen a cumulative increase of 1.64%. However, it is essential to note that the stock has experienced a decline of 6.17% over the past month and a more significant drop of 30.29% over the last year, highlighting the volatility and challenges faced in the agricultural sector.
Market Capitalization and Shareholder Impact
As of the latest trading session, Bayer CropScience boasts a market capitalization of ₹14,905.04 crore. The substantial dividend payout is expected to attract both existing and potential investors, as it signals the company’s commitment to returning value to its shareholders. The decision to declare such a high dividend is particularly noteworthy in the context of the company's recent performance and the broader market conditions.
Investors are keenly watching the stock, especially with the upcoming record date. The eligibility criteria mean that shareholders must purchase shares before November 12 to receive the dividend. This has led to increased trading activity as investors position themselves to benefit from the payout.
Strategic Outlook and Future Prospects
Looking ahead, Bayer CropScience's management is optimistic about the company's growth trajectory. The agricultural sector is poised for growth, driven by increasing demand for food production and sustainable farming practices. The company’s strategic initiatives, including investments in research and development, are expected to enhance its product offerings and market reach.
Moreover, the recent financial results indicate that Bayer CropScience is navigating the challenges of the agricultural market effectively. The increase in net profit suggests that the company is not only maintaining its market position but also capitalizing on opportunities for growth. As the agricultural landscape evolves, Bayer CropScience is well-positioned to adapt and thrive.
Conclusion: A Dividend to Watch
The announcement of a ₹90 dividend per share is a significant event for Bayer CropScience and its shareholders. With the record date approaching, investors are encouraged to consider their positions carefully. The financial results for Q2 FY27 further bolster confidence in the company's operational health and future prospects. As Bayer CropScience continues to navigate the complexities of the agricultural sector, its commitment to shareholder returns remains a focal point for investors.
| Metric | Q2 FY27 | Q2 FY26 | Change (%) |
|---|---|---|---|
| Net Profit | ₹166.2 crore | ₹152.7 crore | +8.9% |
| Net Profit Before Tax (PBT) | ₹211.4 crore | N/A | +6% |
| Share Price (Closing) | ₹3316.50 | N/A | +0.45% |
| Market Capitalization | ₹14,905.04 crore | N/A | N/A |





